164 related articles for article (PubMed ID: 36722192)
21. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.
Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Kuma S; Kuma K; Futami H; Yamaguchi K
World J Surg; 2000 Nov; 24(11):1367-72. PubMed ID: 11038208
[TBL] [Abstract][Full Text] [Related]
22. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
23. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
24. Medullary thyroid carcinoma.
Pacini F; Castagna MG; Cipri C; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
[TBL] [Abstract][Full Text] [Related]
26. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
27. Surgical aspects and controversies in the management of medullary thyroid cancer.
Green K; Hintze J; O'Neill JP
Ir J Med Sci; 2022 Dec; 191(6):2461-2466. PubMed ID: 35064534
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
Torresan F; Cavedon E; Mian C; Iacobone M
World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
[TBL] [Abstract][Full Text] [Related]
29. Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.
Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Haas OA; Vierhapper H; Niederle B
Am J Surg Pathol; 2001 Oct; 25(10):1245-51. PubMed ID: 11688458
[TBL] [Abstract][Full Text] [Related]
30. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
[TBL] [Abstract][Full Text] [Related]
31. Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines.
Zhang D; Colombo C; Sun H; Kim HY; Pino A; De Leo S; Gazzano G; Persani L; Dionigi G; Fugazzola L
Front Endocrinol (Lausanne); 2022; 13():875875. PubMed ID: 35898450
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
Frank-Raue K; Machens A; Leidig-Bruckner G; Rondot S; Haag C; Schulze E; Lorenz A; Kreissl MC; Dralle H; Raue F; Schmid KW
Thyroid; 2013 Mar; 23(3):294-300. PubMed ID: 22946486
[TBL] [Abstract][Full Text] [Related]
33. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.
Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Ito Y; Nakano K; Kuma K; Futami H; Yamaguchi K
World J Surg; 2002 Aug; 26(8):1023-8. PubMed ID: 12016484
[TBL] [Abstract][Full Text] [Related]
34. [The treatment of medullary thyroid cancer].
Fujita T; Fujimori M
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Elisei R; Cosci B; Romei C; Bottici V; Renzini G; Molinaro E; Agate L; Vivaldi A; Faviana P; Basolo F; Miccoli P; Berti P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2008 Mar; 93(3):682-7. PubMed ID: 18073307
[TBL] [Abstract][Full Text] [Related]
36. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
[TBL] [Abstract][Full Text] [Related]
37. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Utility of Procalcitonin for Sporadic Medullary Thyroid Carcinoma in Patients with Nodular Disease and Mild or Moderate Hypercalcitoninemia.
Rosario PW; Mourão GF
Horm Metab Res; 2022 Apr; 54(4):220-223. PubMed ID: 35413742
[TBL] [Abstract][Full Text] [Related]
39. Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986.
Girelli ME; Nacamulli D; Pelizzo MR; De Vido D; Mian C; Piccolo M; Busnardo B
Thyroid; 1998 Jun; 8(6):517-23. PubMed ID: 9669290
[TBL] [Abstract][Full Text] [Related]
40. Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study.
Jiao Z; Wu T; Jiang M; Jiang S; Jiang K; Peng J; Luo G; Yu Y; Chen W; Yang A
Front Endocrinol (Lausanne); 2022; 13():1094242. PubMed ID: 36589824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
